サンプル依頼リスト カート
  • English
  • Korean
  • Traditional Chinese
  • Simplified Chinese
デフォルト表紙
市場調査レポート
商品コード
1598546

乳児臨床栄養の世界市場 - 世界の業界分析、規模、シェア、成長、動向、予測（2031年）

Infant Clinical Nutrition Market - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast 2031

出版日
ページ情報
英文 159 Pages
納期
2～5営業日
価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=143.57円
乳児臨床栄養の世界市場 - 世界の業界分析、規模、シェア、成長、動向、予測（2031年）
出版日: 2024年11月18日
発行: Fairfield Market Research
ページ情報: 英文 159 Pages
納期: 2～5営業日
GIIご利用のメリット
  • 全表示
  • 概要
  • 目次
概要

世界の乳児臨床栄養の市場規模は、2024年から2031年までの予測期間中に6.1％のCAGRで拡大すると予測されています。2024年に275億3,000万米ドルと評価された同市場は、出生率の増加、消費者の意識の高まり、栄養科学の進歩に後押しされ、2031年には416億8,000万米ドルに達すると予測されています。

乳幼児臨床栄養製品に対する需要は、乳幼児の健康ニーズに対する意識の高まりと早産の蔓延により増加傾向にあります。世界保健機関（WHO）によると、年間1,500万人以上の早産児が誕生しており、栄養豊富なサプリメントの必要性が強調されています。その結果、ミルクベース、大豆ベース、オーガニック、プロバイオティクス／プレバイオティクス製品など、製品処方の革新が市場成長の原動力となっています。

世界の出生率は、特に発展途上国において上昇しており、乳児用栄養製品に対する需要の増加を生み出しています。政府およびヘルスケア機関は早産の予後改善に積極的に取り組んでおり、市場をさらに押し上げています。

当レポートでは、世界の乳児臨床栄養市場について調査し、市場の概要とともに、製品タイプ別、投与経路別、地域別動向、および市場に参入する企業の競合動向などを提供しています。

目次

第1章 エグゼクティブサマリー

第2章 市場概要

  • 市場の定義とセグメンテーション
  • 市場力学
  • バリューチェーン分析
  • ポーターのファイブフォース分析
  • COVID-19の影響分析
  • ウクライナ・ロシア紛争の影響
  • 経済概要
  • PESTLE分析

第3章 世界の乳児臨床栄養市場の見通し、2019年～2031年

  • 世界の乳児臨床栄養市場の見通し、製品タイプ別、金額（10億米ドル）、2019年～2031年
  • 世界の乳児臨床栄養市場の見通し、投与経路別、金額（10億米ドル）、2019年～2031年
  • 世界の乳児臨床栄養市場の見通し、地域別、金額（10億米ドル）、2019年～2031年

第4章 北米の乳児臨床栄養市場の見通し、2019年～2031年

第5章 欧州の乳児臨床栄養市場の見通し、2019年～2031年

第6章 アジア太平洋の乳児臨床栄養市場の見通し、2019年～2031年

第7章 ラテンアメリカの乳児臨床栄養市場の見通し、2019年～2031年

第8章 中東・アフリカの乳児臨床栄養市場の見通し、2019年～2031年

第9章 競合情勢

  • 製品タイプと投与経路別ヒートマップ
  • 企業市場シェア分析、2024年
  • 競合ダッシュボード
  • 企業プロファイル
    • Abbott Laboratories
    • Baxter International Inc.
    • Nestle S.A.
    • Danone
    • Meiji Holdings Co., Ltd.,
    • Fresenius SE & Co. KGaA
    • Reckitt Benckiser Group Plc
    • Perrigo Co. Plc
    • Ingredion Inc.
    • Solace Nutrition

第10章 付録

目次

The global infant clinical nutrition market is projected to expand at a CAGR of 6.1% during the forecast period from 2024 to 2031. Valued at US$ 27.53 billion in 2024, the market is expected to reach US$ 41.68 billion by 2031, fueled by increasing birth rates, rising consumer awareness, and advancements in nutritional science.

The demand for infant clinical nutrition products is on the rise due to growing awareness of infant health needs and the prevalence of premature births. According to the World Health Organization (WHO), more than 15 million preterm babies are born annually, emphasizing the need for nutrition-rich supplements. As a result, innovations in product formulations, including milk-based, soy-based, organic, and probiotic/prebiotic products, are driving market growth.

Key Market Drivers

1.Increasing Birth Rates and Premature Births:

  • Global birth rates are rising, particularly in developing nations, creating an increased demand for infant nutritional products.
  • Governments and healthcare organizations are actively working to improve the outcomes of preterm births, further boosting the market.

2.Consumer Awareness and Lifestyle Changes:

  • With rising female labor force participation, dual-income households are increasingly investing in premium nutritional products for their infants.
  • Growing awareness about infant health needs and nutritional supplements is driving the demand for high-quality products.

3.Demand for Premium Products:

  • Parents are willing to spend more on premium-quality infant nutrition products due to improved purchasing power and heightened health consciousness.

4.Technological Advancements:

  • Continuous research in biotechnology is enabling manufacturers to develop specialized products that cater to diverse nutritional needs, improving metabolic and developmental outcomes.

Opportunities in the Market

1.Innovation in Product Development:

  • Manufacturers are focusing on developing advanced formulations, including organic and probiotic-based products, to meet specific infant needs.
  • Incorporation of cutting-edge technologies and neonatal care research is paving the way for more effective nutritional solutions.

2.Geographical Expansion:

  • Emerging markets in South Asia, East Asia, and Africa are becoming key areas of growth due to rising birth rates and increased awareness of infant health.

3.Strategic Investments:

  • Multinational players are heavily investing in research, branding, and supply chain optimization to strengthen their market position.

Challenges Facing the Market

Stringent regulations from authorities such as the U.S. Food and Drug Administration (FDA) and the European Food Safety Authority (EFSA) impose strict quality standards. Manufacturers must comply with nutrient specifications and labeling requirements, often resulting in prolonged approval procedures and higher production costs.

Regional Insights

North America:

  • North America is a prominent region in the infant clinical nutrition market, driven by advancements in food nutrition.
  • The increasing adoption of clean-label trends significantly contributes to the region's market growth.

Europe:

  • Europe plays a key role in the market, with a growing preference for premium-quality infant nutrition products.
  • Capital investments in the food sector and rising consumer awareness about nutritional supplements are major growth factors.

Asia-Pacific:

  • Asia-Pacific is emerging as the fastest-growing region in the infant clinical nutrition market.
  • Population growth and improvements in healthcare infrastructure are key drivers boosting market expansion in this region.

Competitive Analysis

The infant clinical nutrition market is highly competitive, with multinational players dominating the landscape. Companies are focusing on R&D, branding, and innovative product launches to attract new customers and retain existing ones.

Key Players Include:

  • Abbott Laboratories
  • Baxter International
  • Nestle S.A.
  • Danone
  • Meiji Holdings Co., Ltd.
  • Fresenius SE & Co. KGaA
  • Reckitt Benckiser Group Plc
  • Perrigo Co. Plc
  • Ingredion Inc.
  • Solace Nutrition

These companies are leveraging advanced technologies and efficient production processes to enhance product offerings and meet rising consumer demands.

Infant Clinical Nutrition Market Segmentation

1.By Product Type:

  • Milk-Based
  • Soy-Based
  • Organic
  • Probiotic/Prebiotic

2.By Route of Administration:

  • Oral Administration
  • Enteral Administration
  • Intravenous Administration

3.By Region:

  • North America
  • Latin America
  • Europe
  • South Asia & Pacific
  • East Asia
  • Middle East & Africa

Table of Contents

1. Executive Summary

  • 1.1. Global Infant Clinical Nutrition Market Snapshot
  • 1.2. Future Projections
  • 1.3. Key Market Trends
  • 1.4. Regional Snapshot, by Value, 2024
  • 1.5. Analyst Recommendations

2. Market Overview

  • 2.1. Market Definitions and Segmentations
  • 2.2. Market Dynamics
    • 2.2.1. Drivers
    • 2.2.2. Restraints
    • 2.2.3. Market Opportunities
  • 2.3. Value Chain Analysis
  • 2.4. Porter's Five Forces Analysis
  • 2.5. COVID-19 Impact Analysis
    • 2.5.1. Supply
    • 2.5.2. Demand
  • 2.6. Impact of Ukraine-Russia Conflict
  • 2.7. Economic Overview
    • 2.7.1. World Economic Projections
  • 2.8. PESTLE Analysis

3. Global Infant Clinical Nutrition Market Outlook, 2019 - 2031

  • 3.1. Global Infant Clinical Nutrition Market Outlook, by Product Type, Value (US$ Bn), 2019 - 2031
    • 3.1.1. Key Highlights
      • 3.1.1.1. Milk-Based
      • 3.1.1.2. Soy-Based
      • 3.1.1.3. Organic
      • 3.1.1.4. Probiotic/Prebiotic
  • 3.2. Global Infant Clinical Nutrition Market Outlook, by Route of Administration, Value (US$ Bn), 2019 - 2031
    • 3.2.1. Key Highlights
      • 3.2.1.1. Oral administration
      • 3.2.1.2. Enteral administration
      • 3.2.1.3. Intravenous administration
  • 3.3. Global Infant Clinical Nutrition Market Outlook, by Region, Value (US$ Bn), 2019 - 2031
    • 3.3.1. Key Highlights
      • 3.3.1.1. North America
      • 3.3.1.2. Europe
      • 3.3.1.3. Asia Pacific
      • 3.3.1.4. Latin America
      • 3.3.1.5. Middle East & Africa

4. North America Infant Clinical Nutrition Market Outlook, 2019 - 2031

  • 4.1. North America Infant Clinical Nutrition Market Outlook, by Product Type, Value (US$ Bn), 2019 - 2031
    • 4.1.1. Key Highlights
      • 4.1.1.1. Milk-Based
      • 4.1.1.2. Soy-Based
      • 4.1.1.3. Organic
      • 4.1.1.4. Probiotic/Prebiotic
  • 4.2. North America Infant Clinical Nutrition Market Outlook, by Route of Administration, Value (US$ Bn), 2019 - 2031
    • 4.2.1. Key Highlights
      • 4.2.1.1. Oral administration
      • 4.2.1.2. Enteral administration
      • 4.2.1.3. Intravenous administration
    • 4.2.2. BPS Analysis/Market Attractiveness Analysis
  • 4.3. North America Infant Clinical Nutrition Market Outlook, by Country, Value (US$ Bn), 2019 - 2031
    • 4.3.1. Key Highlights
      • 4.3.1.1. U.S. Infant Clinical Nutrition Market by Product Type, Value (US$ Bn), 2019 - 2031
      • 4.3.1.2. U.S. Infant Clinical Nutrition Market by Route of Administration, Value (US$ Bn), 2019 - 2031
      • 4.3.1.3. Canada Infant Clinical Nutrition Market by Product Type, Value (US$ Bn), 2019 - 2031
      • 4.3.1.4. Canada Infant Clinical Nutrition Market by Route of Administration, Value (US$ Bn), 2019 - 2031
    • 4.3.2. BPS Analysis/Market Attractiveness Analysis

5. Europe Infant Clinical Nutrition Market Outlook, 2019 - 2031

  • 5.1. Europe Infant Clinical Nutrition Market Outlook, by Product Type, Value (US$ Bn), 2019 - 2031
    • 5.1.1. Key Highlights
      • 5.1.1.1. Milk-Based
      • 5.1.1.2. Soy-Based
      • 5.1.1.3. Organic
      • 5.1.1.4. Probiotic/Prebiotic
  • 5.2. Europe Infant Clinical Nutrition Market Outlook, by Route of Administration, Value (US$ Bn), 2019 - 2031
    • 5.2.1. Key Highlights
      • 5.2.1.1. Oral administration
      • 5.2.1.2. Enteral administration
      • 5.2.1.3. Intravenous administration
    • 5.2.2. BPS Analysis/Market Attractiveness Analysis
  • 5.3. Europe Infant Clinical Nutrition Market Outlook, by Country, Value (US$ Bn), 2019 - 2031
    • 5.3.1. Key Highlights
      • 5.3.1.1. Germany Infant Clinical Nutrition Market by Product Type, Value (US$ Bn), 2019 - 2031
      • 5.3.1.2. Germany Infant Clinical Nutrition Market by Route of Administration, Value (US$ Bn), 2019 - 2031
      • 5.3.1.3. U.K. Infant Clinical Nutrition Market by Product Type, Value (US$ Bn), 2019 - 2031
      • 5.3.1.4. U.K. Infant Clinical Nutrition Market by Route of Administration, Value (US$ Bn), 2019 - 2031
      • 5.3.1.5. France Infant Clinical Nutrition Market by Product Type, Value (US$ Bn), 2019 - 2031
      • 5.3.1.6. France Infant Clinical Nutrition Market by Route of Administration, Value (US$ Bn), 2019 - 2031
      • 5.3.1.7. Italy Infant Clinical Nutrition Market by Product Type, Value (US$ Bn), 2019 - 2031
      • 5.3.1.8. Italy Infant Clinical Nutrition Market by Route of Administration, Value (US$ Bn), 2019 - 2031
      • 5.3.1.9. Turkey Infant Clinical Nutrition Market by Product Type, Value (US$ Bn), 2019 - 2031
      • 5.3.1.10. Turkey Infant Clinical Nutrition Market by Route of Administration, Value (US$ Bn), 2019 - 2031
      • 5.3.1.11. Russia Infant Clinical Nutrition Market by Product Type, Value (US$ Bn), 2019 - 2031
      • 5.3.1.12. Russia Infant Clinical Nutrition Market by Route of Administration, Value (US$ Bn), 2019 - 2031
      • 5.3.1.13. Rest of Europe Infant Clinical Nutrition Market by Product Type, Value (US$ Bn), 2019 - 2031
      • 5.3.1.14. Rest of Europe Infant Clinical Nutrition Market by Route of Administration, Value (US$ Bn), 2019 - 2031
    • 5.3.2. BPS Analysis/Market Attractiveness Analysis

6. Asia Pacific Infant Clinical Nutrition Market Outlook, 2019 - 2031

  • 6.1. Asia Pacific Infant Clinical Nutrition Market Outlook, by Product Type, Value (US$ Bn), 2019 - 2031
    • 6.1.1. Key Highlights
      • 6.1.1.1. Milk-Based
      • 6.1.1.2. Soy-Based
      • 6.1.1.3. Organic
      • 6.1.1.4. Probiotic/Prebiotic
  • 6.2. Asia Pacific Infant Clinical Nutrition Market Outlook, by Route of Administration, Value (US$ Bn), 2019 - 2031
    • 6.2.1. Key Highlights
      • 6.2.1.1. Oral administration
      • 6.2.1.2. Enteral administration
      • 6.2.1.3. Intravenous administration
    • 6.2.2. Others BPS Analysis/Market Attractiveness Analysis
  • 6.3. Asia Pacific Infant Clinical Nutrition Market Outlook, by Country, Value (US$ Bn), 2019 - 2031
    • 6.3.1. Key Highlights
      • 6.3.1.1. China Infant Clinical Nutrition Market by Product Type, Value (US$ Bn), 2019 - 2031
      • 6.3.1.2. China Infant Clinical Nutrition Market by Route of Administration, Value (US$ Bn), 2019 - 2031
      • 6.3.1.3. Japan Infant Clinical Nutrition Market by Product Type, Value (US$ Bn), 2019 - 2031
      • 6.3.1.4. Japan Infant Clinical Nutrition Market by Route of Administration, Value (US$ Bn), 2019 - 2031
      • 6.3.1.5. South Korea Infant Clinical Nutrition Market by Product Type, Value (US$ Bn), 2019 - 2031
      • 6.3.1.6. South Korea Infant Clinical Nutrition Market by Route of Administration, Value (US$ Bn), 2019 - 2031
      • 6.3.1.7. India Infant Clinical Nutrition Market by Product Type, Value (US$ Bn), 2019 - 2031
      • 6.3.1.8. India Infant Clinical Nutrition Market by Route of Administration, Value (US$ Bn), 2019 - 2031
      • 6.3.1.9. Southeast Asia Infant Clinical Nutrition Market by Product Type, Value (US$ Bn), 2019 - 2031
      • 6.3.1.10. Southeast Asia Infant Clinical Nutrition Market by Route of Administration, Value (US$ Bn), 2019 - 2031
      • 6.3.1.11. Rest of Asia Pacific Infant Clinical Nutrition Market by Product Type, Value (US$ Bn), 2019 - 2031
      • 6.3.1.12. Rest of Asia Pacific Infant Clinical Nutrition Market by Route of Administration, Value (US$ Bn), 2019 - 2031
    • 6.3.2. BPS Analysis/Market Attractiveness Analysis

7. Latin America Infant Clinical Nutrition Market Outlook, 2019 - 2031

  • 7.1. Latin America Infant Clinical Nutrition Market Outlook, by Product Type, Value (US$ Bn), 2019 - 2031
    • 7.1.1. Key Highlights
      • 7.1.1.1. Milk-Based
      • 7.1.1.2. Soy-Based
      • 7.1.1.3. Organic
      • 7.1.1.4. Probiotic/Prebiotic
  • 7.2. Latin America Infant Clinical Nutrition Market Outlook, by Route of Administration, Value (US$ Bn), 2019 - 2031
    • 7.2.1. Key Highlights
      • 7.2.1.1. Oral administration
      • 7.2.1.2. Enteral administration
      • 7.2.1.3. Intravenous administration
    • 7.2.2. BPS Analysis/Market Attractiveness Analysis
  • 7.3. Latin America Infant Clinical Nutrition Market Outlook, by Country, Value (US$ Bn), 2019 - 2031
    • 7.3.1. Key Highlights
      • 7.3.1.1. Brazil Infant Clinical Nutrition Market by Product Type, Value (US$ Bn), 2019 - 2031
      • 7.3.1.2. Brazil Infant Clinical Nutrition Market by Route of Administration, Value (US$ Bn), 2019 - 2031
      • 7.3.1.3. Mexico Infant Clinical Nutrition Market by Product Type, Value (US$ Bn), 2019 - 2031
      • 7.3.1.4. Mexico Infant Clinical Nutrition Market by Route of Administration, Value (US$ Bn), 2019 - 2031
      • 7.3.1.5. Argentina Infant Clinical Nutrition Market by Product Type, Value (US$ Bn), 2019 - 2031
      • 7.3.1.6. Argentina Infant Clinical Nutrition Market by Route of Administration, Value (US$ Bn), 2019 - 2031
      • 7.3.1.7. Rest of Latin America Infant Clinical Nutrition Market by Product Type, Value (US$ Bn), 2019 - 2031
      • 7.3.1.8. Rest of Latin America Infant Clinical Nutrition Market by Route of Administration, Value (US$ Bn), 2019 - 2031
    • 7.3.2. BPS Analysis/Market Attractiveness Analysis

8. Middle East & Africa Infant Clinical Nutrition Market Outlook, 2019 - 2031

  • 8.1. Middle East & Africa Infant Clinical Nutrition Market Outlook, by Product Type, Value (US$ Bn), 2019 - 2031
    • 8.1.1. Key Highlights
      • 8.1.1.1. Milk-Based
      • 8.1.1.2. Soy-Based
      • 8.1.1.3. Organic
      • 8.1.1.4. Probiotic/Prebiotic
  • 8.2. Middle East & Africa Infant Clinical Nutrition Market Outlook, by Route of Administration, Value (US$ Bn), 2019 - 2031
    • 8.2.1. Key Highlights
      • 8.2.1.1. Oral administration
      • 8.2.1.2. Enteral administration
      • 8.2.1.3. Intravenous administration
    • 8.2.2. BPS Analysis/Market Attractiveness Analysis
  • 8.3. Middle East & Africa Infant Clinical Nutrition Market Outlook, by Country, Value (US$ Bn), 2019 - 2031
    • 8.3.1. Key Highlights
      • 8.3.1.1. GCC Infant Clinical Nutrition Market by Product Type, Value (US$ Bn), 2019 - 2031
      • 8.3.1.2. GCC Infant Clinical Nutrition Market by Route of Administration, Value (US$ Bn), 2019 - 2031
      • 8.3.1.3. South Africa Infant Clinical Nutrition Market by Product Type, Value (US$ Bn), 2019 - 2031
      • 8.3.1.4. South Africa Infant Clinical Nutrition Market by Route of Administration, Value (US$ Bn), 2019 - 2031
      • 8.3.1.5. Egypt Infant Clinical Nutrition Market by Product Type, Value (US$ Bn), 2019 - 2031
      • 8.3.1.6. Egypt Infant Clinical Nutrition Market by Route of Administration, Value (US$ Bn), 2019 - 2031
      • 8.3.1.7. Nigeria Infant Clinical Nutrition Market by Product Type, Value (US$ Bn), 2019 - 2031
      • 8.3.1.8. Nigeria Infant Clinical Nutrition Market by Route of Administration, Value (US$ Bn), 2019 - 2031
      • 8.3.1.9. Rest of Middle East & Africa Infant Clinical Nutrition Market by Product Type, Value (US$ Bn), 2019 - 2031
      • 8.3.1.10. Rest of Middle East & Africa Infant Clinical Nutrition Market by Route of Administration, Value (US$ Bn), 2019 - 2031
    • 8.3.2. BPS Analysis/Market Attractiveness Analysis

9. Competitive Landscape

  • 9.1. Product Type vs by Route of Administration Heatmap
  • 9.2. Company Market Share Analysis, 2024
  • 9.3. Competitive Dashboard
  • 9.4. Company Profiles
    • 9.4.1. Abbott Laboratories
      • 9.4.1.1. Company Overview
      • 9.4.1.2. Product Portfolio
      • 9.4.1.3. Financial Overview
      • 9.4.1.4. Business Strategies and Development
    • 9.4.2. Baxter International Inc.
      • 9.4.2.1. Company Overview
      • 9.4.2.2. Product Portfolio
      • 9.4.2.3. Financial Overview
      • 9.4.2.4. Business Strategies and Development
    • 9.4.3. Nestle S.A.
      • 9.4.3.1. Company Overview
      • 9.4.3.2. Product Portfolio
      • 9.4.3.3. Financial Overview
      • 9.4.3.4. Business Strategies and Development
    • 9.4.4. Danone
      • 9.4.4.1. Company Overview
      • 9.4.4.2. Product Portfolio
      • 9.4.4.3. Financial Overview
      • 9.4.4.4. Business Strategies and Development
    • 9.4.5. Meiji Holdings Co., Ltd.,
      • 9.4.5.1. Company Overview
      • 9.4.5.2. Product Portfolio
      • 9.4.5.3. Financial Overview
      • 9.4.5.4. Business Strategies and Development
    • 9.4.6. Fresenius SE & Co. KGaA
      • 9.4.6.1. Company Overview
      • 9.4.6.2. Product Portfolio
      • 9.4.6.3. Financial Overview
      • 9.4.6.4. Business Strategies and Development
    • 9.4.7. Reckitt Benckiser Group Plc
      • 9.4.7.1. Company Overview
      • 9.4.7.2. Product Portfolio
      • 9.4.7.3. Financial Overview
      • 9.4.7.4. Business Strategies and Development
    • 9.4.8. Perrigo Co. Plc
      • 9.4.8.1. Company Overview
      • 9.4.8.2. Product Portfolio
      • 9.4.8.3. Financial Overview
      • 9.4.8.4. Business Strategies and Development
    • 9.4.9. Ingredion Inc.
      • 9.4.9.1. Company Overview
      • 9.4.9.2. Product Portfolio
      • 9.4.9.3. Financial Overview
      • 9.4.9.4. Business Strategies and Development
    • 9.4.10. Solace Nutrition
      • 9.4.10.1. Company Overview
      • 9.4.10.2. Product Portfolio
      • 9.4.10.3. Financial Overview
      • 9.4.10.4. Business Strategies and Development

10. Appendix

  • 10.1. Research Methodology
  • 10.2. Report Assumptions
  • 10.3. Acronyms and Abbreviations